Echo IQ (ASX:EIQ) Partners with Mayo Clinic Platform, Advances EchoSolv HF towards FDA Clearance
Echo IQ (ASX:EIQ) partners with Mayo Clinic Platform to advance EchoSolv HF and progress towards FDA clearance for its heart failure solution.
Category: Information Technology
Bigtincan Holdings Limited (ASX:BTH) Announces Proposed Acquisition and Option Scheme
Bigtincan Holdings Limited (ASX:BTH) announces a proposed acquisition by Big Wombat and outlines share and option schemes for shareholder approval.
Atomos Limited (ASX:AMS) Enters $13.7m Debt Facility
Atomos Limited (ASX:AMS) secures a $13.7m debt facility to achieve cashflow positivity by FY26, avoiding equity dilution.
PlaySide Studios (ASX:PLY) Announces Operations Restructure
PlaySide Studios (ASX:PLY) restructures operations to optimize costs while maintaining focus on major IP projects and future growth.
Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Anatomy
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
xReality Group Limited (ASX:XRG) Executes Debt Refinancing Term Sheet
xReality Group Limited (ASX:XRG) enters into a debt refinancing agreement with Causeway Asset Management to strengthen its financial position and support growth.
Archer Materials (ASX:AXE) Appoints Dr Simon Ruffell as CEO
Archer Materials (ASX:AXE) appoints Dr Simon Ruffell as CEO, enhancing leadership with his extensive experience in semiconductor and quantum technologies.
Healius (ASX:HLS) Announces Pathology Strategy and $300M Dividend at Investor Day 2025
Healius (ASX:HLS) reveals a new pathology strategy and a $300 million special dividend during Investor Day 2025.
Tuas Limited (ASX:TUA) Releases Interim Financial Report
Tuas Limited (ASX:TUA) reports a 34% revenue increase and returns to profitability in its latest interim financial report.
I Synergy Group Limited (ASX:IS3) Requests Trading Halt for Capital Raising
I Synergy Group Limited (ASX:IS3) requests a trading halt to complete a proposed capital raising, expected to resume by 27 March 2025.